发明名称 HETEROCYCLO CALCIUM ANTAGONISTS
摘要 The present invention is directed to a new class of cyclic guanidines of the formula: <CHEM> in which Q is represented by a substituent selected from the group consisting of (CH2)n in which n is an integer from 2-10, <CHEM> A is a substituent selected from the group consisting of -NH-(CH2)m in which m is an integer from 0-5, a piperidino substituent, or a piperazino substituent; both Ar and Ar1 are each independently represented by a phenyl ring, each of which may be optionally substituted with up to 3 substituents, each selected from the group consisting of halogen, alkyl, alkoxy, hydroxy, and trifluoromethyl; and R is represented by either hydrogen or an alkyl; R1 is represented by hydrogen or an alkyl; the tautomers, and optical isomers thereof; and the pharmaceutically acceptable acid addition salts thereof; with the provisos that: 1) when Q is represented by (CH2)2,3,or 4 , then A is not represented by NH-(CH2)o; and 2) when Q is represented by (CH2)2 and R is an alkyl; then A is not NH-(CH2), and to their use as calcium antagonists.
申请公布号 AU4932590(A) 申请公布日期 1990.08.16
申请号 AU19900049325 申请日期 1990.02.09
申请人 MERRELL DOW PHARMACEUTICALS INC. 发明人 ALBERT A. CARR;JOHN M. KANE;HSIEN C. CHENG
分类号 A61K;A61K31/395;A61K31/415;A61K31/505;A61K31/55;A61P3/00;A61P3/14;A61P9/06;A61P9/08;A61P9/10;A61P9/12;A61P19/06;A61P25/08;A61P25/24;A61P25/26;C07D;C07D233/48;C07D233/50;C07D235/30;C07D239/14;C07D239/84;C07D243/04;C07D245/02;C07D245/06;C07D401/04 主分类号 A61K
代理机构 代理人
主权项
地址